Evidence map›Paper›PMID 42173878›Full record

ArticleNature communications2026

A Rahman Syndrome mutation in histone H1.4 disrupts chromatin compaction and phase separation.

Ramachandran Boopathi, Isabel Garcia-Saez, Serhan Turunç, Imtiaz Nisar Lone, Ashok Kumar, Abed Alkarem Abu Alhaija, Jeffrey J Hayes, Jan Bednar, Muhammed Kasim Diril, Dimitar Iliev and 8 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Ramachandran Boopathi *Univ. Grenoble Alpes, CNRS, CEA, Institut de Biologie Structurale (IBS), Grenoble, France.
Isabel Garcia-Saez *Univ. Grenoble Alpes, CNRS, CEA, Institut de Biologie Structurale (IBS), Grenoble, France.
Serhan Turunç *Izmir Biomedicine and Genome Center, Dokuz Eylül University Health Campus, Izmir, Turkey.ORCID http://orcid.org/0000-0001-7956-0059
Imtiaz Nisar LoneIzmir Biomedicine and Genome Center, Dokuz Eylül University Health Campus, Izmir, Turkey.ORCID http://orcid.org/0000-0002-1137-2569
Ashok KumarUniversity of Rochester Medical Center, Rochester, NY, USA.ORCID http://orcid.org/0000-0001-6482-0137
Abed Alkarem Abu AlhaijaIzmir Biomedicine and Genome Center, Dokuz Eylül University Health Campus, Izmir, Turkey.ORCID http://orcid.org/0000-0001-8081-0940
Jeffrey J HayesUniversity of Rochester Medical Center, Rochester, NY, USA.ORCID http://orcid.org/0000-0001-6981-1803
Jan BednarUniv. Grenoble Alpes, Inserm, CNRS, Institute for Advanced Biosciences (IAB), Grenoble, France.
Muhammed Kasim DirilIzmir Biomedicine and Genome Center, Dokuz Eylül University Health Campus, Izmir, Turkey.ORCID http://orcid.org/0000-0002-3644-4178
Dimitar IlievRoumen Tsanev Institute of Molecular Biology, Bulgarian Academy of Sciences, Sofia, Bulgaria.
Anastas GospodinovRoumen Tsanev Institute of Molecular Biology, Bulgarian Academy of Sciences, Sofia, Bulgaria.
Aline Le RoyUniv. Grenoble Alpes, CNRS, CEA, Institut de Biologie Structurale (IBS), Grenoble, France.ORCID http://orcid.org/0000-0003-2760-6347
Dimitrios SkoufiasUniv. Grenoble Alpes, CNRS, CEA, Institut de Biologie Structurale (IBS), Grenoble, France.ORCID http://orcid.org/0000-0001-5595-3413
Dimitar AngelovIzmir Biomedicine and Genome Center, Dokuz Eylül University Health Campus, Izmir, Turkey. dimitar_angelov@yahoo.com.ORCID http://orcid.org/0000-0002-5511-6647
Ali HamicheInstitut de Génétique et Biologie Moléculaire et Cellulaire (IGBMC), Université de Strasbourg, CNRS, INSERM, Illkirch, France. hamiche@igbmc.fr.ORCID http://orcid.org/0000-0002-7859-6372
Seyit KaleIzmir Biomedicine and Genome Center, Dokuz Eylül University Health Campus, Izmir, Turkey. seyit.kale@ibg.edu.tr.ORCID http://orcid.org/0000-0001-7903-8543
Stefan DimitrovUniv. Grenoble Alpes, Inserm, CNRS, Institute for Advanced Biosciences (IAB), Grenoble, France. stefan.dimitrov@univ-grenoble-alpes.fr.ORCID http://orcid.org/0000-0002-1326-3630
Carlo PetosaUniv. Grenoble Alpes, CNRS, CEA, Institut de Biologie Structurale (IBS), Grenoble, France. carlo.petosa@ibs.fr.ORCID http://orcid.org/0000-0002-9975-1167

Funding

Molecular mechanisms of the core and linker histone tail domains that drive chromatin condensationR35GM149420 · NIGMS · UNIVERSITY OF ROCHESTER · PI Jeffrey J Hayes · 2023 to 2026
$1.6M
Agence Nationale de la Recherche (French National Research Agency) ANR-17-EURE-0003Agence Nationale de la Recherche (French National Research Agency) ANR-21-CE12-0017European Molecular Biology Organization (EMBO) Installation Grant No. 5056NIGMS NIH HHS R35 GM149420
6 · The paper itself

Abstract

Rahman syndrome is a rare developmental disorder caused by frameshift mutations in linker histone H1.4 that produce a truncated carboxy-terminal domain with reduced positive charge. We investigated the effects of a disease-associated mutation on chromatin structure and dynamics, focusing on H1.4-bound nucleosomes and hexanucleosomal arrays. We report that this mutation induces a more extended and flexible array conformation, characterized by enhanced linker DNA accessibility and an inability to form compact, regularly stacked nucleosome structures. Notably, mutant H1.4-bound arrays show a reduced capacity to undergo liquid-liquid and liquid-solid phase separation, closely resembling linker histone-free arrays. Molecular dynamics simulations corroborated by fluorescence resonance energy transfer measurements indicate that the mutated carboxy-terminal domain interacts with a shorter linker DNA segment, resulting in a more open nucleosome conformation. Consistent with these structural changes, the mutation significantly enhances H1.4 mobility within cell nuclei, reflecting a weaker chromatin association. The combined data suggest that Rahman syndrome-associated mutations promote an aberrantly relaxed chromatin state, potentially leading to the dysregulation of gene expression that may drive disease pathology. These findings underscore the essential role of the carboxy-terminal domain in chromatin compaction and provide mechanistic insights into the molecular etiology of Rahman syndrome.

Indexed as

ChromatinHistonesChromatin Assembly and DisassemblyDNAFluorescence Resonance Energy TransferHumansMolecular Dynamics SimulationMutationNucleosomesPhase SeparationChromatinDNAHistonesNucleosomes

Identifiers

PMID42173878
PMCPMC13385758

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.